Oramed Pharmaceuticals Stock Analysis

Oramed Stock Analysis Notes

About 17.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oramed Pharmaceuticals had not issued any dividends in recent years. The entity had 1:12 split on the 23rd of January 2013. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Oramed Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Oramed Pharmaceuticals contact Nadav Esq at 844 967 2633 or learn more at https://www.oramed.com.

Oramed Pharmaceuticals Investment Alerts

Oramed Pharmaceuticals Upcoming and Recent Events

Oramed Largest EPS Surprises

View All Earnings Estimates

Oramed Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Oramed Stock Institutional Investors

Note, although Oramed Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Oramed Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 94.58 M.

Oramed Profitablity

Management Efficiency

Oramed Pharmaceuticals has return on total asset (ROA) of (0.0412) % which means that it has lost $0.0412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0289 %, meaning that it created $0.0289 on every $100 dollars invested by stockholders. Oramed Pharmaceuticals' management efficiency ratios could be used to measure how well Oramed Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Oramed Pharmaceuticals' Return On Tangible Assets are relatively stable compared to the past year. As of 01/31/2025, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop (0.09). At this time, Oramed Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 01/31/2025, Liabilities And Stockholders Equity is likely to grow to about 266.3 M, while Non Current Liabilities Total is likely to drop slightly above 4.2 M.

Technical Drivers

As of the 31st of January, Oramed Pharmaceuticals holds the Coefficient Of Variation of (2,655), variance of 4.82, and Risk Adjusted Performance of (0.03). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oramed Pharmaceuticals, as well as the relationship between them.

Oramed Pharmaceuticals Price Movement Analysis

Oramed Pharmaceuticals Insider Trading Activities

Oramed Pharmaceuticals Outstanding Bonds

Oramed Pharmaceuticals Predictive Daily Indicators

Oramed Pharmaceuticals Corporate Filings

Oramed Pharmaceuticals Forecast Models

Oramed Pharmaceuticals' time-series forecasting models are one of many Oramed Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oramed Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Oramed Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oramed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oramed Pharmaceuticals. By using and applying Oramed Stock analysis, traders can create a robust methodology for identifying Oramed entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oramed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oramed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Oramed Pharmaceuticals stock analysis indicators help investors evaluate how Oramed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Oramed Pharmaceuticals shares will generate the highest return on investment. By understating and applying Oramed Pharmaceuticals stock analysis, traders can identify Oramed Pharmaceuticals position entry and exit signals to maximize returns.

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.